Gentag signs license agreement to develop and commercialize post surgery wireless skin patch

NewsGuard 100/100 Score

Gentag, Inc. and The CORE Institute® are pleased to announce the signing of a license agreement to develop and commercialize a disposable wireless skin patch to allow patients to self monitor themselves in the comfort of their homes after orthopedic surgery in hospitals through the use of cell phones.

The technology will help reduce post-orthopedic surgical-related medical costs by reducing the time spent in hospitals and detecting possible problems much earlier with less pain and risk, and costing much less than existing technology.

The technology combines advanced MEMS sensors and Gentag's disposable wireless platform sensor that is directly compatible with cell phones integrating standard NFC-ISO 15693 hybrid reader chip technology.  Such cell phones include the iPhone via a soon-to-be released RFID retrofit, thereby ensuring broad access by consumers to the technology. Clinical trials are expected to begin in 2010.

"The CORE Institute®, their physicians and research team have the required medical expertise and involvement in the orthopedics arena to bring this new technology through the FDA approval process to benefit patients worldwide," announced Dr. John Peeters, the founder of Gentag. "We are pleased to sign this agreement and look forward to supporting The CORE Institute® and its partners to commercialize this new technology and other related technologies."

"The CORE Institute® is pleased to secure the funding required for the final development of this important technology platform that will decrease the cost of care, while improving patient safety and outcomes, by giving patients the tools to detect post orthopedic surgery complications in the comfort of their homes," announced David Jacofsky, MD, the Chairman and CEO of The CORE Institute®.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Bariatric surgery outperforms traditional treatments for long-term diabetes control